Showing results (71-80 of 86) with videos related to
Sort By:
Pageof 9
Molecular Cancer Research : MCR|May 13, 2021
EGR1 Addiction in Diffuse Large B-cell LymphomaShuichi Kimpara, Li Lu, Nguyet M Hoang, et al.Cancer|November 14, 2015
Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphomaDaniel J Landsburg, Adam M Petrich, Jeremy S Abramson, et al.Clinical Lymphoma, Myeloma & Leukemia|December 25, 2018
Multicenter Analysis of Advanced Stage Grade 3A Follicular Lymphoma Outcomes by Frontline Treatment RegimenNirav N Shah, Aniko Szabo, Raya Saba, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2012
Development and characterization of HPV-positive and HPV-negative head and neck squamous cell carcinoma tumorgraftsRandall J Kimple, Paul M Harari, Alexandra D Torres, et al.British Journal of Haematology|August 19, 2011
VcR-CVAD induction chemotherapy followed by maintenance rituximab in mantle cell lymphoma: a Wisconsin Oncology Network studyJulie E Chang, Christopher Peterson, Sangbum Choi, et al.Leukemia|May 25, 2019
PRMT5 is upregulated by B-cell receptor signaling and forms a positive-feedback loop with PI3K/AKT in lymphoma cellsFen Zhu, Hui Guo, Paul D Bates, et al.The Journal of Experimental Medicine|August 15, 2012
Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphomaMark J Kiel, Thirunavukkarasu Velusamy, Bryan L Betz, et al.Blood|April 30, 2010
Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphomaVioletta V Leshchenko, Pei-Yu Kuo, Rita Shaknovich, et al.British Journal of Haematology|July 30, 2016
Sole rearrangement but not amplification of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiableDaniel J Landsburg, Marissa K Falkiewicz, Adam M Petrich, et al.Journal of the National Comprehensive Cancer Network : JNCCN|October 6, 2020
Chronic Myeloid Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in OncologyMichael W Deininger, Neil P Shah, Jessica K Altman, et al.Pageof 9